Lumos Pharma, Inc.
Lumos Pharma, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for rare diseases. Its lead therapeutic candidate LUM-201 is an oral growth hormone secretagogue ibutamoren, which is in Phas…
Biotechnology
US, Austin [HQ]
Revenue Breakdowns
Segment Analysis Beta
The financial segments are sourced from the SEC' 10-K statement.Revenue By Top Segments
Lumos Pharma, Inc. can't present it's sankey chart.
Historical Revenue By Segment
Last 3Y, in million USDLumos Pharma, Inc. can't present revenue by segment
Get PRO Today
With PRO you can bypass the blur for the segment revenues of Lumos Pharma, Inc..
If you want to see a demo, head over to the financial segments of AAPL